Mapi, Saama Technologies team up to strengthen analytics enabled business outcomes for customers

Mapi, the market leader in Prospective Real-World Evidence generation, Health Research Analytics and Evidence Synthesis announces their collaboration with Saama Technologies, Inc., the leading Big Data solutions company.

The initial phase of this partnership establishes a framework to integrate Saama's extensive experience bringing comprehensive data and advanced analytics solutions with Mapi's industry leading expertise in qualitative and quantitative analytics; both Mapi and Saama are investing in synchronization of processes, standards and technology enablement for a seamless experience to our mutual customers. The joint offering enables access to state of the art data mining, visualization tools and expertise to manage Data Oceans with Mapi's unmatched analytics and insight expertise in Health Economics, Patient Outcomes, Adherence, Epidemiology, Drug Safety and Patient Engagement Patient Perspectives.

James Karis, Mapi's CEO, commented, "This new partnership provides our customers with the benefit of Mapi's over 40 years in Patient-Centered research combined with the ability to more efficiently and effectively use technology to interpret and analyze real time data from international studies with higher data quality and speed than has previously been possible."

Saama's Fluid Analytics™ for Life Sciences delivers proven services, methodology and technology for rapidly orchestrating and analysing large volumes of data. Their hybrid approach blends technology acceleration with human expertise and industry-specific data assets, enabling better business outcomes with speed and specificity. Now global pharmaceutical companies can make better clinical decisions before and after a product is introduced to the market, ultimately bringing safer, more effective products to patients in less time.

Additionally, Mapi and Saama have already initiated an expert engagement process to work with Mapi's industry leading Real-World Evidence teams to provide patient perspectives through social media mining. Drug regulatory agencies and health care payers are now considering social media information as part of their decision making process. The combined solution is designed to identify the key patterns in social media content to provide insight on patient perspective and experience to help health care companies meet these new expectations.

Murali Krishnam, VP - Life Sciences Analytics Solutions, commented, "Saama's strategic partnership with Mapi will further strengthen our 19 years of creating analytics enabled business outcomes for our customers by combining our life sciences industry specific data analytics solutions and Mapi's Patient-Centered research expertise. The combined assets will embed analytics right within processes to provide just-in-moment and guided clinical decisions for our mutual customers."

This comprehensive solution supports data integration, storage, classification, text mining and sentiment analysis of social media and provides a query engine interface that will be utilized by Mapi experts to derive key patient insights. The next phase of the collaboration will focus on Mapi's expertise in Patient Centered Services to support life science companies in their integration of patient engagement methodologies into their Clinical Trials and Post-Approval Research Programs.